Literature DB >> 20844220

Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621.

Gisela Santella, Simona Pollini, Jean-Denis Docquier, Ana Irina Mereuta, Gabriel Gutkind, Gian Maria Rossolini, Marcela Radice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20844220      PMCID： PMC3020820          DOI： 10.1128/JCM.00614-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  15 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  Full Resistance and decreased susceptibility to carbapenems in IMP-13-producing Pseudomonas aeruginosa isolates from an outbreak.

Authors:  Gisela Santella; Arabela Cuirolo; Marisa Almuzara; Susana Palombarani; Gabriela Sly; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

3.  Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase.

Authors:  Laura Pagani; Céline Colinon; Roberta Migliavacca; Maria Labonia; Jean-Denis Docquier; Elisabetta Nucleo; Melissa Spalla; Michele Li Bergoli; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  A general method for detecting and sizing large plasmids.

Authors:  B M Barton; G P Harding; A J Zuccarelli
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

5.  Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.

Authors:  Barry Curran; Daniel Jonas; Hajo Grundmann; Tyrone Pitt; Christopher G Dowson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit.

Authors:  G Miranda; C Kelly; F Solorzano; B Leanos; R Coria; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.

Authors:  Mark A Toleman; Doug Biedenbach; David M C Bennett; Ronald N Jones; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2004-12-01       Impact factor: 5.790

Review 8.  Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily.

Authors:  Carine Bebrone
Journal:  Biochem Pharmacol       Date:  2007-06-02       Impact factor: 5.858

9.  Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria.

Authors:  S L Liu; A Hessel; K E Sanderson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

10.  Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme.

Authors:  Mark A Toleman; Doug Biedenbach; David Bennett; Ronald N Jones; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790
View more
  7 in total

1.  Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility.

Authors:  C Slekovec; J Robert; D Trystram; J M Delarbre; A Merens; N van der Mee-Marquet; C de Gialluly; Y Costa; J Caillon; D Hocquet; X Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-07       Impact factor: 3.267

2.  Dissemination of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa in Romania.

Authors:  Laurent Dortet; Mirela Flonta; Yves-Marie Boudehen; Elodie Creton; Sandrine Bernabeu; Anaïs Vogel; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

3.  Population structure of clinical Pseudomonas aeruginosa from West and Central African countries.

Authors:  Pascal Cholley; Roughyatou Ka; Christophe Guyeux; Michelle Thouverez; Nathalie Guessennd; Beniam Ghebremedhin; Thierry Frank; Xavier Bertrand; Didier Hocquet
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

4.  Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains.

Authors:  Thibaud Boulant; Yves-Marie Boudehen; Alain Filloux; Patrick Plesiat; Thierry Naas; Laurent Dortet
Journal:  Front Microbiol       Date:  2018-10-29       Impact factor: 5.640

5.  Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: Predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii.

Authors:  Javier E Cañada-García; Natalin Grippo; Eva Ramírez de Arellano; Verónica Bautista; Noelia Lara; Ana María Navarro; Teresa Cabezas; Nora Mariela Martínez-Ramírez; Silvia García-Cobos; Jorge Calvo; Emilia Cercenado; Belén Aracil; María Pérez-Vázquez; Jesús Oteo-Iglesias
Journal:  Front Microbiol       Date:  2022-09-28       Impact factor: 6.064

6.  Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.

Authors:  Odile Milan; Laurent Debroize; Xavier Bertrand; Patrick Plesiat; Anne-Sophie Valentin; Roland Quentin; Nathalie Van der Mee-Marquet
Journal:  Antimicrob Resist Infect Control       Date:  2013-04-04       Impact factor: 4.887

7.  Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase.

Authors:  Charlotte A Softley; Krzysztof M Zak; Mark J Bostock; Roberto Fino; Richard Xu Zhou; Marta Kolonko; Ramona Mejdi-Nitiu; Hannelore Meyer; Michael Sattler; Grzegorz M Popowicz
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.